Stoke Therapeutics develops RNA-based medicines, led by zorevunersen, a candidate in clinical testing for Dravet syndrome, a severe genetic epilepsy. It last closed at $26.81 on Nov 20, down 0.45% on the day. The next earnings report for STOK is expected around Mon, Jan 11, 2027. For the quarter ended Sep 2026, STOK reported EPS of -$1.08 on revenue of $11.3M, with revenue up 5.9% from a year ago. Over its last 8 reports the stock moved an average of 7.8% the session after earnings. Over the last 12 months STOK insiders bought $0 of stock on the open market and sold $7.9M, according to SEC Form 4 filings.
AI Auto Pilots
Is STOK in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold STOK.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on STOKStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
STOK · as of the Nov 20 close · updated each morning
Bounce inside a longer downtrend
The stock is 1% above its 20 day and 2% above its 50 day average. It is 14% below its 200 day average, so the longer trend is down. Momentum is improving (RSI 52). The nearest support is the 20 day average at $26.66, and the nearest resistance the Pivot at $26.84.
Short trendBullish
Long trendBearish
MomentumImproving
StretchNormal
VolatilityNormal, 4.9%/day
Key levels
$40.2252 week high+50.0%
$30.67200 day average+14.4%
$28.54100 day average+6.5%
$27.75Pivot R1+3.5%
$27.22Swing high (Oct 20)+1.5%
$26.84Pivot+0.1%
$26.81Last close
$26.6620 day average−0.6%
$26.1650 day average−2.4%
$25.91Pivot S1−3.4%
$25.65Swing low (Nov 13)−4.3%
$22.0552 week low−17.8%
Indicators
RSI (14)
52.07
Middle of its range
Neutral
MACD
0.18
Above its signal line
Bullish
Stochastic
41.6
Middle of its range
Neutral
ADX (14)
15.1
No clear trend
Williams %R
-58.4
Oversold below −80, overbought above −20
Neutral
CCI (20)
31.7
Oversold below −100, overbought above 100
Neutral
Rate of change
+1.0%
Change over 10 sessions
Bullish
ATR (14)
$1.32
Typical daily range, 4.9% of price
MA 10Below
MA 20Above
MA 50Above
MA 100Below
MA 200Below
Pullback inside a longer uptrend
Short trendBearish
Long trendBullish
MomentumWeak
StretchNormal
VolatilityLow, 11.1%/day
Key levels
$40.2252 week high+50.0%
$30.67200 day average+14.4%
$28.54100 day average+6.5%
$27.75Pivot R1+3.5%
$27.22Swing high (Oct 20)+1.5%
$26.84Pivot+0.1%
$26.81Last close
$26.6620 day average−0.6%
$26.1650 day average−2.4%
$25.91Pivot S1−3.4%
$25.65Swing low (Nov 13)−4.3%
$22.0552 week low−17.8%
Indicators
RSI (14)
44.72
Middle of its range
Neutral
MACD
-1.28
Below its signal line
Bearish
Stochastic
38.9
Middle of its range
Neutral
ADX (14)
16.5
No clear trend
Williams %R
-60.0
Oversold below −80, overbought above −20
Neutral
CCI (20)
-44.0
Oversold below −100, overbought above 100
Neutral
Rate of change
−7.7%
Change over 10 sessions
Bearish
ATR (14)
$2.98
Typical daily range, 11.1% of price
MA 10Above
MA 20Below
MA 50Below
MA 100Above
MA 200Above
What happened before, for STOK
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how STOK did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow STOK usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for STOKHow many large options trades hit STOK, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in STOK in the last 90 days.
From SEC Form 4 filings by STOK's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether STOK is in one of them and how their past STOK trades turned out.
Stoke Therapeutics is a biopharmaceutical company based in Bedford, Massachusetts, that develops RNA-based medicines. Its TANGO approach uses antisense oligonucleotides to raise levels of specific proteins in diseases caused by a shortage of one working gene copy. Its lead candidate, zorevunersen, is in late stage clinical testing for Dravet syndrome, a severe genetic epilepsy. The company focuses on diseases of the brain and eye and plans to sell its medicines to patients and healthcare providers in the United States, Canada and Mexico.